Skip to main content
SpringerLink
Log in

Biologischer und mechanischer Herzersatz

  • Chapter
  • First Online:
Kompendium der modernen Herzchirurgie beim Erwachsenen

  • 3620 Accesses

Zusammenfassung

Die Herztransplantation als biologischer Herzersatz ist heute immer noch die effektivste Therapie der terminalen Herzinsuffizienz. Die Auswahl des optimalen Empfängers, aber auch die Spenderselektion werden ausführlich dargestellt, ebenso die verschiedenen Techniken der Organentnahme im Spender als auch die orthotope Implantation des Herzens im Empfänger. Die heute nur noch kasuistisch angewandte heterotope Herztransplantation wird kurz vorgestellt. Perioperative Komplikationen, aber auch der postoperative Verlauf mit der nach Transplantation obligaten Immunsuppression, der Physiologie des transplantierten Herzens bis hin zur Endomyocardbiopsie und Retransplantation, werden beleuchtet. Die Geschichte des Kunstherzens (total artificial heart – mechanischer Herzersatz), seine Indikation, die Implantation und die weiteren Entwicklungen auf diesem innovativen Gebiet werden kurz dargestellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Change history

  • 20 June 2020

    Erratum zu:

Literatur

  • Aaronson KD, Schwartz JS, Chen T-M et al (1997) Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95:2660–2667

    CAS  PubMed  Google Scholar 

  • Alba AC, Rao V, Ross HJ et al (2010) Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients. J Heart Lung Transplant 29:1253–1258

    PubMed  Google Scholar 

  • Angermann EC, Spes CH, Tammen A et al (1990) Anatomic characteristics and valvular function of the transplanted heart: transthoracic versus transesophageal echocardiographic findings. J Heart Transplant 9:331–338

    CAS  PubMed  Google Scholar 

  • Antretter H, Hangler H, Hoefer D et al (2002a) Totaler und partieller Herzersatz – Trends und Entwicklungen. J Kardiol 9:3–13

    Google Scholar 

  • Antretter H, Poelzl G, Margreiter J et al (2002b) Successful transfer of a cardiac allograft from a heterotop to an orthotopic position 16 years after heart transplantation. Transplantation 74:540–543

    PubMed  Google Scholar 

  • Antretter H, Hoefer D, Hangler H et al (2004) Long-term outcome of cytomegalovirus high risk patients after heart transplantation: comparison between two prophylactic regimes -a single center experience. Eur Surg 36:113–120

    Google Scholar 

  • Antretter H, Hintringer F, Hangler H et al (2006) Electromechanical synchronization of the heterotopic and native heart by biatrial stimulation following heart transplantation. Europace 8:279–282

    CAS  PubMed  Google Scholar 

  • Aull MJ, Buell JF, Trofe J et al (2004) Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry. Transplantation 78:1676–1682

    PubMed  Google Scholar 

  • Bailey LL (2000) Current opinion in heart transplantation: an introduction: editorial commentary. Curr Opin Organ Transplant 5:115–117

    Google Scholar 

  • Barnard CN (1967) The operation. S Afr Med J 41:1271–1274

    CAS  PubMed  Google Scholar 

  • Barnard CN (1968) Human cardiac transplantation: an evaluation of the first two operations performed at the Groote Schuur Hospital, Cape Town. Am J Cardiol 22:791–803

    Google Scholar 

  • Bassi N, Jeevanandam V (2017) Choosing the right heart: proper donor selection in cardiac transplantation. Curr Opin Cardiol 32:286–291

    Google Scholar 

  • Batista RJV, Santos JLV, Takeshita N et al (1996) Partial left ventriculectomy to improve left ventricular function in end–stage heart disease. J Card Surg 11:96–97

    CAS  PubMed  Google Scholar 

  • Billingham ME (1985) Endomyocardial biopsy detection of acute rejection in cardiac allograft recipients. Heart Vessels Suppl 1:86–90

    CAS  PubMed  Google Scholar 

  • Billingham M, Kobashigawa JA (2005) The revised ISHLT heart biopsy grading scale. Editorial J Heart Lung Transplant 24:1709

    Google Scholar 

  • Billingham ME, Cary NRB, Hammond ME et al (1990) A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. J Heart Lung Transplant 9:587–593

    CAS  Google Scholar 

  • Blanche C, Takkenberg JJM, Nessim S et al (1996) Heart transplantation in patients 65 years of age and older: a comparative analysis of 40 patients. Ann Thorac Surg 62:1442–1447

    CAS  PubMed  Google Scholar 

  • Bonatti H, Tabarelli W, Ruttmann E et al (2004) Impact of cytomegalovirus match on survival after cardiac and lung transplantation. Am Surg 70:710–714

    PubMed  Google Scholar 

  • Bonatti H, Hoefer D, Rogatsch H et al (2005) Successful management of recurrent Epstein-Barr virus-associated multilocular leiomyosarcoma after cardiac transplantation. Transplant Proc 37:1839–1844

    CAS  PubMed  Google Scholar 

  • Boucek MM, Mathis CM, Kanakriyeh MS et al (1993) Donor shortage: use of the dysfunctional donor heart. J Heart Lung Transplant 12:186–190

    Google Scholar 

  • Brown ME, Sarris GE, Oyer PE (1996) Cardiac donor evaluation, retrieval, and matching to recipient. In: Smith JA, MacCarthy PM, Sarris GE, Stinson EB, Reitz BA (Hrsg) The Stanford manual of cardiopulmonary transplantation. Futura Publishing Company, Armonk, S 15–30

    Google Scholar 

  • Calne RY (1979) Immunosuppression for organ grafting – observations on cyclosporin A. Immunol Rev 46:113–124

    Google Scholar 

  • Cantin B, Gao SZ, Kwok BWK et al (2002) Prognosis of patients with significant angiographically diagnosed cardiac allograft coronary disease. J Heart Lung Transplant 21:96

    Google Scholar 

  • Carpentier A, Latremouille C, Cholley B et al (2015) First clinical use of a bioprosthetic total artificial heart: report of two cases. Lancet 386:1556–1563

    PubMed  Google Scholar 

  • Caves PK, Billingham ME, Stinson EB et al (1974) Serial transvenous biopsy of the transplanted human heart. Improved management of acute rejection episodes. Lancet 1:821–826

    CAS  PubMed  Google Scholar 

  • Collins EG, Mozdzierz GJ (1993) Cardiac retransplantation: determining limits. Heart Lung 22:206–212

    CAS  PubMed  Google Scholar 

  • Cooley DA, Liotta D, Hallman GL et al (1969) Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol 24:723–730

    CAS  PubMed  Google Scholar 

  • Cooper DKC, Taniguchi S (1996) Heterotopic heart transplantation – Indications, surgical techniques and special considerations. In: Cooper DKC, Miller LW, Patterson GA (Hrsg) The transplantation and replacement of thoracic organs. Kluwer Academic Publishers, Dordrecht/Boston.London, S 353–365

    Google Scholar 

  • Copeland JG (1995) Only optimal donors should be accepted for heart transplantation: protagonist. J Heart Lung Transplant 14:1038–1043

    CAS  PubMed  Google Scholar 

  • Copeland JG, Smith R, Icenogle T et al (1989) Orthotopic total artificial heart bridge to transplantation: preliminary results. J Heart Lung Transplant 8:124–137

    CAS  Google Scholar 

  • Copeland JG, Smith RG, Arabia FA et al (2000) The CardioWest total artificial heart as a bridge to transplantation. Sem Thorac Cardiovasc Surg 12:238–242

    CAS  Google Scholar 

  • Copeland JG, Smith RG, Arabia FA et al (2004) Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med 351:859–867

    CAS  PubMed  Google Scholar 

  • Deleuze PH, Benvenuti C, Mazzuccotelli JP et al (1995) Orthotopic cardiac transplantation with direct caval anastomosis: is it the optimal procedure? J Thorac Cardiovasc Surg 109:731–737

    CAS  PubMed  Google Scholar 

  • Derumeaux G, Habib G, Schleifer DM et al (1995) Standard orthotopic heart transplantation versus total orthotopic heart transplantation. A transesophageal echocardiography study of the incidence of left atrial thrombosis. Circulation 92II:196–201

    Google Scholar 

  • DeVries W (1988) The permanent artificial heart: four case reports. JAMA 259:849–859

    CAS  PubMed  Google Scholar 

  • Dichtl W, Vogel W, Dunst KM et al (2005) Cardiac hepatopathy before and after heart transplantation. Transpl Int 18:697–702

    PubMed  Google Scholar 

  • Dierickx D, Habermann TM (2018) Post-transplantation lymphoproliferative disorders in adults. N Engl J Med 378:549–562

    CAS  PubMed  Google Scholar 

  • DiSalvo T, Naftel D, Kasper EK et al (1998) The differing hazard of lymphoma vs. other malignancies in the current era – a multiinstitutional study [abstract]. J Heart Lung Transplant 17:70

    Google Scholar 

  • Doval HC, Nul DR, Grancelli HO et al (1996) Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death. Circulation 94:3198–3203

    CAS  PubMed  Google Scholar 

  • Dreyfus G, Jebara V, Mihaileanu S et al (1991) Total orthotopic heart transplantation: an alternative to standard technique. Ann Thorac Surg 52:1181–1184

    CAS  PubMed  Google Scholar 

  • Dubin AM, Berul CI, Bevilacqua LM et al (2003) The use of implantable cardioverter-defibrillators in pediatric patients awaiting heart transplantation. J Card Fail 9:375–379

    PubMed  Google Scholar 

  • Dyke CM, Yeh T, Lehman JD et al (1991) Triiodothyronine-enhanced left ventricular function after ischemic injury. Ann Thorac Surg 52:14–19

    CAS  PubMed  Google Scholar 

  • Eisen HJ (2004) Pathogenesis and management of cardiac allograft vasculopathy. Curr Opin Organ Transplant 9:448–452

    Google Scholar 

  • Eisen H, Kobashigawa J, Starling RC (2005) Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors. Transplant Proc 37(Suppl. 4S):4–17

    Google Scholar 

  • Gradman AH, Deedwania PC (1994) Predictors of mortality in patients with heart failure. Cardiol Clin 12:25–35

    CAS  PubMed  Google Scholar 

  • Grady D (1984) Summery of discussion on ethical perspectives. In: Shaw M (Hrsg) After Barney Clark: reflections on the Utah artificial heart program. University of Texas Press, Austin, S 25–41

    Google Scholar 

  • Gray J, Wreghitt TG, Pavel P et al (1995) Ebstein-Barr virus infection in heart and heart/lung transplant recipients: incidence and clinical impact. J Heart Lung Transplant 14:640

    CAS  PubMed  Google Scholar 

  • Greene M, Newman D, Geist M et al (2000) Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Europace 2:263–269

    CAS  PubMed  Google Scholar 

  • Griffith BP, Kormos RL, Nastala CJ et al (1996) Results of extended bridge to transplantation: window into the future of permanent ventricular assist devices. Ann Thorac Surg 61:359–365

    Google Scholar 

  • Hoefer D, Bonatti H, Poelzl G et al (2005) Cecal perforation as a rare initial manifestation of posttransplant lymphoproliferative disorder after cardiac transplantation. J Heart Lung Transplant 24:505–506

    PubMed  Google Scholar 

  • Hoefer D, Aliabadi A, Ebner C et al (2010) Der potentielle Organspender – Evaluierung unter besonderer Berücksichtigung der Herzentnahme. Wien Klin Wochenschr 122:441–451

    Google Scholar 

  • Hosenpud JD, Bennett LE, Keck BM et al (1997) The registry of the International Society for Heart and Lung Transplantation: fourteenth official report – 1997. J Heart Lung Transplant 16:691–712

    Google Scholar 

  • Hosenpud JD, Bennett LE, Keck BM et al (1999) The registry of the International Society for Heart and Lung Transplantation: sixteenth official report – 1999. J Heart Lung Transplant 18:611–626

    Google Scholar 

  • Hosenpud JD, Bennett LE, Keck BM et al (2000) The registry of the International Society for Heart and Lung Transplantation: seventeenth official report – 2000. J Heart Lung Transplant 19:909–931

    Google Scholar 

  • Iberer F, Grasser B, Schreier G et al (1998) Introducing a new clinical method for noninvasive rejection monitoring after heart transplantation to clinical practice: analysis of paced intramyocardial electrograms. Transplant Proc 30:895–899

    CAS  PubMed  Google Scholar 

  • Ikonen TS, Gummert JF, Hayase M et al (2000) Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primates. Transplantation 70:1773–1780

    Google Scholar 

  • Jamieson SW, Burton NA, Bieber CP et al (1979) Cardiac-allograft survival in primates treated with cyclosporin A. Lancet 10:545

    Google Scholar 

  • John R, Chen JM, Weinber A et al (1999) Long-term survival after cardiac retransplantation: a twenty-year single-center experience. J Thorac Cardiovasc Surg 117:543–555

    CAS  PubMed  Google Scholar 

  • Kirklin JW, Barratt-Boyes BG (1993) Primary cardiomyopathy and cardiac transplantation. In: Kirklin JW, Barratt-Boyes BG (Hrsg) Cardiac surgery. Churchill Livingstone, New York/Edinburgh/London/Melbourne/Tokyo, S 1655–1681

    Google Scholar 

  • Kirklin JK, Young JB, McGiffin DC (2002a) Recipient evaluation and selection. In: Kirklin JK, Young JB, McGiffin DC (Hrsg) Heart transplantation. Churchill Livingstone, New York/Edinburgh/London/Philadelphia, S 198–231

    Google Scholar 

  • Kirklin JK, Young JB, McGiffin DC (2002b) The donor heart. In: Kirklin JK, Young JB, McGiffin DC (Hrsg) Heart transplantation. Churchill Livingstone, New York/Edinburgh/London/Philadelphia, S 293–338

    Google Scholar 

  • Kirklin JK, Young JB, McGiffin DC (2002c) The heart transplant operation. In: Kirklin JK, Young JB, McGiffin DC (Hrsg) Heart transplantation. Churchill Livingstone, New York/Edinburgh/London/Philadelphia, S 339–352

    Google Scholar 

  • Kirklin JK, Young JB, McGiffin DC (2002d) Physiology of the transplanted heart. In: Kirklin JK, Young JB, McGiffin DC (Hrsg) Heart transplantation. Churchill Livingstone, New York/Edinburgh/London/Philadelphia, S 353–372

    Google Scholar 

  • Kirklin JK, Young JB, McGiffin DC (2002e) Cardiac allograft rejection. In: Kirklin JK, Young JB, McGiffin DC (Hrsg) Heart transplantation. Churchill Livingstone, New York/Edinburgh/London/Philadelphia, S 464–520

    Google Scholar 

  • Klima U, Ringes-Lichtenberg S, Warnecke G et al (2005) Severe right heart failure after heart transplantation. A single-center experience. Transpl Int 18:326–332

    PubMed  Google Scholar 

  • Kobashigawa J, Miller L, Renlund D et al (1998) A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate mofetil investigators. Transplantation 66:507–515

    CAS  PubMed  Google Scholar 

  • Konig A, Theisen K, Klauss V (2000) Intravascular ultrasound for assessment of coronary allograft vasculopathy. Z Kardiol 89(Suppl 9):45–49

    Google Scholar 

  • Laks H (1995) Only optimal donors should be accepted for heart transplantation: antagonist. J Heart Lung Transplant 14: 1043–1046

    Google Scholar 

  • Latremouille C, Carpentier A, Leprince P et al (2018) A bioprosthetic total artificial heart for end-stage heart failure: results from a pilot study. J Heart Lung Transplant 37:33–37

    Google Scholar 

  • Libby P (1996) Transplantation associated arteriosclerosis: potential mechanisms. In: Tilney N, Storm T, Paul L (Hrsg) Transplantation biology: cellular and molecular aspects. Lippincott-Raven, Philadelphia, S 577–586

    Google Scholar 

  • Lietz K, John R, Mancini DM et al (2004) Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; implications for donor selection criteria. J Am Coll Cardiol 4:1553–1561

    Google Scholar 

  • Linde C, Braunschweig F, Gadler F et al (2003) Long-term improvements in quality of life by biventricular pacing in patients with chronic heart failure: results from the multisite stimulation in cardiomyopathy study (MUSTIC). Am J Cardiol 91:1090–1095

    PubMed  Google Scholar 

  • Losman JG, Barnard CN (1977) Hemodynamic evaluation of left ventricular bypass with a homologous cardiac graft. J Thorac Cardiovasc Surg 74:695–708

    CAS  PubMed  Google Scholar 

  • Lower RR, Shumway NE (1960) Studies on orthotopic transplantation of the canine heart. Surg Forum 11:18–19

    CAS  PubMed  Google Scholar 

  • Magovern GJ, Simpson KA (1996) Clinical cardiomyoplasty: review of the ten-year United States experience. Ann Thorac Surg 61:413–419

    PubMed  Google Scholar 

  • Mallidi HR, Bates M (2017) Pacemaker use following heart transplantation. Ochsner J 17:20–24

    PubMed  PubMed Central  Google Scholar 

  • Mancini D, Lietz K (2010) Selection of cardiac transplantation candidates in 2010. Circulation 122:173–183

    PubMed  Google Scholar 

  • Mancini DM, Eisen H, Kussmaul W et al (1991) Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83:778–786

    CAS  PubMed  Google Scholar 

  • Marelli D, Laks H, Kobashigawa JA et al (2002) Seventeen-year experience with 1,083 heart transplants at a single institution. Ann Thorac Surg 74:1558–1566

    PubMed  Google Scholar 

  • McCarthy PM, Smith JA, Siegel LC et al (1996) Cardiac transplant admission, ansthesia and operative procedures. In: Smith JA, MacCarthy PM, Sarris GE, Stinson EB, Reitz BA (Hrsg) The Stanford manual of cardiopulmonary transplantation. Futura Publishing Company, Armonk, S 31–61

    Google Scholar 

  • McCarthy PM, Starling RC, Wong J et al (1997) Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg 114:755–763

    CAS  PubMed  Google Scholar 

  • Melton IC, Gilligan DM, Wood MA et al (1999) Optimal cardiac pacing after heart transplantation. Pacing Clin Electrophysiol 22:1510–1527

    CAS  PubMed  Google Scholar 

  • Meyer SR, Modry DL, Bainey K et al (2005) Declining need for permanent pacemaker insertion with the bicaval technique of orthotopic heart transplantation. Can J Cardiol 21:159–163

    PubMed  Google Scholar 

  • Miniati DN, Robbin RC (2002) Heart transplantation: a thirty-year perspective. Annu Rev Med 53:189–205

    CAS  PubMed  Google Scholar 

  • Mohanty PK, Thomas MD, Arrowood JA et al (1987) Impairment of cardiopulmonary baroreflex after cardiac transplantation in humans. Circulation 75:21

    Google Scholar 

  • Moreira LFP, Stolf NAG, Braile DM et al (1996) Dynamic cardiomyoplasty in South America. Ann Thorac Surg 61:413–419

    Google Scholar 

  • Morgan JA, Edwards NM (2005) Orthotopic cardiac transplantation: comparison of outcome using biatrial, bicaval, and total techniques. J Card Surg 20:102–106

    PubMed  Google Scholar 

  • Newcomb AE, Esmore DS, Rosenfeldt FL et al (2004) Heterotopic heart transplantation: an expanding role in the twenty-first century? Ann Thorac Surg 78:1345–1351

    PubMed  Google Scholar 

  • Novitzky D, Cooper DKC, Reichart B (1987) Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 43:852–854

    CAS  PubMed  Google Scholar 

  • Platis A, Larson DF (2009) CardioWest termporary total artificial heart. Perfusion 24:341–348

    PubMed  Google Scholar 

  • Poelzl G, Ullrich R, Huber A et al (2005) Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy. Transpl Int 18:313–317

    PubMed  Google Scholar 

  • Poston RS, Griffith BP (2004) Heart transplantation. J Intensive Care Med 19:3–12

    PubMed  Google Scholar 

  • Radovancevic B, McGiffin DC, Kobashigawa JA et al (2003) Retransplantation in 7,290 primary transplant patients: a 10-year multi-institutional study. J Heart Lung Transplant 22:862–868

    PubMed  Google Scholar 

  • Razzouk AJ (2000) Cardiac retransplantation. Curr opin Organ Transplant 5:154–157

    Google Scholar 

  • Razzouk AJ, Chinnock RE, Dearani JA et al (1998) Cardiac retransplantation for graft vasculopathy in children: should we continue to do it ? Arch Surg 133:881–885

    CAS  PubMed  Google Scholar 

  • Renlund DG (2004) Building a bridge to heart transplantation. N Engl J Med 351:849–851

    CAS  PubMed  Google Scholar 

  • Roussel JC, Senage T, Baron O et al (2009) CardioWest (Jarvik) total artificial heart: a single-center experience with 42 patients. Ann Thorac Surg 87:124–130

    PubMed  Google Scholar 

  • Sabato LA, Salerno DM, Moretz JD, Jennings DL (2017) Inhaled pulmonary vasodilator therapy for management of right ventricular dysfunction after left ventricular assist device placement and cardiac transplantation. Pharmacotherapy 37:944–955

    CAS  PubMed  Google Scholar 

  • Schnetzler B, Pavie A, Dorent R et al (1998) Heart retransplantation: a 23-year single-center clinical experience. Ann Thorac Surg 65:978–983

    CAS  PubMed  Google Scholar 

  • Segovia J (2002) Update on cardiac allograft vasculopathy. Curr Opin Organ Transplant 7:240–251

    Google Scholar 

  • Shumway NE, Lower RR, Stofer RC (1966) Transplantation of the heart. Adv Surg 2:265–284

    CAS  PubMed  Google Scholar 

  • Stark RP, McGinn AL, Wilson RF (1991) Chest pain in cardiac transplant recipients. Evidence of sensory reinnervation after cardiac transplantation. N Engl J Med 324:1791–1794

    CAS  PubMed  Google Scholar 

  • Stehlik J, Edwards LB, Kucheryavaya AY et al (2010) The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant 29:1089–1103

    PubMed  Google Scholar 

  • Stevenson LW, Tillisch TH, Hamilton M et al (1990) Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20 % secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 66:1348–1354

    Google Scholar 

  • Stewart S, Winters GL, Fishbein MC et al (2005) Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24:1710–1720

    Google Scholar 

  • Taylor DO, Barr ML, Radovancevic B et al (1999) A randomised, multicenter comparison of TAC and CsA immunosuppressive regimes in cardiac transplantation: decreased hyperlipidemia and hypertension with TAC. J Heart Lung Transplant 18:336

    CAS  PubMed  Google Scholar 

  • Tuzku EM, Schoenhagen P, Starling RC et al (2002) Impact of everolimus on allograft vasculopathy: the SDZ RAD/heart intravascular ultrasound study. J Heart Lung Transplant 21:68

    Google Scholar 

  • Uriel N, Jorde UP, Woo Pak S et al (2013) Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation. J Heart Lung Transplant 32:188–195

    PubMed  PubMed Central  Google Scholar 

  • Warnecke H, Müller J, Cohnert T et al (1992) Clinical heart transplantation without routine endomyocardial biopsy. J Heart Lung Transplant 11:1093–1102

    CAS  PubMed  Google Scholar 

  • Watson DC, Reitz BA, Baumgartner WA et al (1979) Distant heart procurement for transplantation. Surgery 86:56–59

    CAS  PubMed  Google Scholar 

  • Wells D, Villa CR, Morales DLS (2017) The 50/50cc total artificial heart trial: extending the benefits of the total artificial heart to underserved populations. Semin Thorac Cardiovasc Surg 20:16–19

    Google Scholar 

  • Wheeldon DR, Potter CDO, Oduro A et al (1995) Transforming the „unacceptable“ donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 14:734–742

    CAS  PubMed  Google Scholar 

  • Yacoub M, Mankad P, Ledingham S (1990) Donor procurement and surgical techniques for cardiac transplantation. Semin Thorac Cardiovasc Surg 2:153–161

    CAS  PubMed  Google Scholar 

  • Yun JJ, Fischbein MP, Laks H et al (2001) Chronic rejection of transplanted hearts. Curr Opin Organ Transplant 6:205–210

    Google Scholar 

  • Zaroff JG, Babcock WD, Shiboski SC et al (2003) Temporal changes in left ventricular systolic function in heart donors: results of serial echocardiography. J Heart Lung Transplant 22:383–388

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Herzchirurgie, Medizinische Universität Innsbruck, Innsbruck, Österreich

    Herwig Antretter & Julia Dumfarth

Authors
  1. Herwig Antretter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julia Dumfarth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Herwig Antretter .

Editor information

Editors and Affiliations

  1. Helios Klinikum München West, Klinik für Gefäßchirurgie Aortenzentrum Süd, München, Germany

    Olaf Stanger

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Austria, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Antretter, H., Dumfarth, J. (2020). Biologischer und mechanischer Herzersatz. In: Stanger, O. (eds) Kompendium der modernen Herzchirurgie beim Erwachsenen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0451-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-0451-4_15

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-0450-7

  • Online ISBN: 978-3-7091-0451-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation